Unknown

Dataset Information

0

Molecular docking and dynamic simulation of approved drugs targeting against spike protein (6VXX) of 2019-nCoV (novel coronavirus)

ABSTRACT:

SUBMITTER: Thakur A 

PROVIDER: S-EPMC9197568 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines.
| S-EPMC7128649 | biostudies-literature
Unknown Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.
| S-EPMC7147283 | biostudies-literature
Unknown Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein.
| S-EPMC8646714 | biostudies-literature
Unknown Potential small-molecule drugs as available weapons to fight novel coronavirus (2019-nCoV): A review.
| S-EPMC7461398 | biostudies-literature
Unknown Genomic variance of the 2019-nCoV coronavirus.
| S-EPMC7166773 | biostudies-literature
Unknown Machine intelligence design of 2019-nCoV drugs.
| S-EPMC7217289 | biostudies-literature
Unknown Novel coronavirus (2019-nCov): do you have enough intensive care units? Nuevo coronavirus (2019-nCov): ¿tiene suficientes unidades de cuidados intensivos?
| S-EPMC7158803 | biostudies-literature
Unknown Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation.
| S-EPMC10287530 | biostudies-literature
Unknown Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2
| S-EPMC9300476 | biostudies-literature
Unknown The coronavirus 2019-nCoV epidemic: Is hindsight 20/20?
| S-EPMC7057189 | biostudies-literature